Dana-Farber Cancer Institute, Inc. and Subsidiaries

Audits
5
Findings
2
Total Expended
$1.18B
Latest Accepted
2025-09-30
Location: Boston, MA
UEI: DPMGH9MG1X67 EIN: 042263040

SAM.gov Exclusion Status:

Checking exclusion status...

Contacts

Name Title Type
Valeria Leite Director, Research Finance Auditee
Melissa Chammas Senior Director Financial Operations Auditee
Sheila Harrington Partner, Audit Auditee
Amit Shrestha MANAGER, RESEARCH FINANCE Auditee
No contacts on file

Recent Audits

ID Year Date Accepted Auditor Spend
369085 2024 2025-09-30 Kpmg LLP $231.21M
359813 2024 2025-06-25 Kpmg LLP $231.21M
332207 2023 2024-12-12 Kpmg LLP $238.93M
307575 2023 2024-05-30 Kpmg LLP $238.93M
32970 2022 2023-06-28 Kpmg LLP $242.67M

Audit Findings

Audit Year Accepted Finding Ref Severity Repeat Requirement
32970 2022 2023-06-28 606769 2022-001 Significant Deficiency - L
32970 2022 2023-06-28 30327 2022-001 Significant Deficiency - L